Genmab A GMAB
NASDAQ GMAB
$39.78 +0.21 (+0.53%)
As of: Oct 22, 2026 · 3:44 PM EDT

Genmab A (GMAB) EV to EBITDA (2026)

Updated

Genmab A's EV to EBITDA was 0.12 in the quarter ended Jun 30, 2026, up 17.8% from the prior quarter.

Analysis

Genmab A (GMAB) EV to EBITDA (2026) Analysis & Trends

On a trailing twelve-month basis, Genmab A's EV to EBITDA was -1.62 through Jun 30, 2026; for the year ended Dec 31, 2025, it was 0.24, down 71.2% from the prior year.

  • In earlier years, EV to EBITDA was 0.83 in the year ended Dec 31, 2024 (-49.0%), 1.63 in the year ended Dec 31, 2023 (+41.9%) and 1.15 in the year ended Dec 31, 2022.
  • Quarterly EV to EBITDA has moved between -0.84 (the quarter ended Jun 30, 2025) and 0.55 (the quarter ended Sep 30, 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,167.71 Bn 1,136.29 Bn 19.71 Bn
2 Johnson & Johnson 647.75 Bn 567.61 Bn 17.30 Bn
3 AbbVie 503.60 Bn 476.71 Bn 12.70 Bn
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn
5 Novartis Ag 303.19 Bn 267.18 Bn 11.24 Bn
6 Astrazeneca 268.04 Bn 241.73 Bn 12.86 Bn
7 Amgen 242.69 Bn 198.09 Bn 7.24 Bn
8 Gilead Sciences 194.89 Bn 169.09 Bn 6.22 Bn
9 Pfizer 173.31 Bn 119.95 Bn 10.94 Bn
10 Genmab A 2.57 Bn -2.80 Bn 1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.28
API Access

Genmab A EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=GMAB&period=max&api_key=YOUR_API_KEY